The sterols β-sitostenone (1), stigmast-4,6,8(14),22-tetraen-3-one (2), β-sitosterol (3) and stigmasterol (4), the aromatic derivatives antiarol (5) and gentisic acid (6), the phenylpropanes coniferyl alcohol (7), epoxyconiferyl alcohol (8) and ferulic acid (9), the apocarotenoid vomifoliol (10), the flavonoids naringenin (11), 7,4 -dimethoxytaxifolin (7,4 -dimethoxydihydroquercetin, 12), aromadendrin (13), kaempferol (14), taxifolin (dihydroquercetin, 15), prunin (naringenin-7-O-β-D-glucoside, 16), populnin (kaempferol-7-O-β-D-glucoside, 17) and senecin (aromadendrin-7-O-β-D-glucoside, 18) and the lignans kobusin (19) and pinoresinol (20), were isolated from the dried bark of Cochlospermum vitifolium Spreng (Cochlospermaceae), a Mexican medicinal plant used to treat jaundice, liver ailments and hepatitis C. Fourteen of these compounds were isolated for the first time from this plant and from the Cochlospermum genus. Compounds 3-4, 6-7, 9-11, 13-17 and 20 have previously exhibited diverse beneficial liver activities. The presence of these compounds in C. vitifolium correlates with the use of this Mexican medicinal plant.
Introduction
The Cochlospermaceae family comprises seven genera: Amoreuxia, Azeredia, Cochlospermum, Euryanthe, Lachnocistus, Maximilianea and Wittelsbachia. In turn, the genus Cochlospermum (syn. Maximilianea and Bixaceae) is composed of 13 species of tropical trees ranging in height from 3 to 15 m, distributed in deciduous forests worldwide [1] . The bark and roots from the Cochlospermum species have been the most studied parts of these plants and only six of the 13 species of Cochlospermum have been chemically analyzed. Within Cochlospermum gillivraei the flavonoids apigenin, naringenin and afzelequin were found [2] ; from Cochlospermum gossypium only carbohydrates were identified [3, 4] ; Cochlospermum planchonii biosynthesized the flavonoids miricetin, quercetin, aromadendrin and cianidin [5] and gallic acid, saponins, tannins, glycosides and carbohydrates [6] . From Cochlospermum regium, the gallic and ellagic acids, the flavonoid dihidrokaempferol-3-O-β-(6"-galloyl)-glucopyranoside and the lignans pinoresinol and excelsin have been isolated [7] . From Cochlospermum tinctorium, the triterpene arjunolic acid, along with tannins and carotenoids, β-bisabolene, 1-dodecanol, 1-hydroxy-3-octadecanone, 2-pentadecanone [8, 9] , alphitolic acid, cochloxantin and dihydrocochloxantin were identified [10] . Finally, the composition of the essential oils obtained from the leaves, root bark and root wood of Cochlospermum vitifolium has been established by GC/MS. The leaves' essential oil consist of four major components:
Results and Discussion
During our ongoing phytochemical research from the dichloromethane extract of the dried bark of Cochlospermum vitifolium, the following metabolites were characterized: the sterols β-sitostenone (1), stigmast-4,6,8(14),22-tetraen-3-one (2), β-sitosterol (3) and stigmasterol (4), the aromatic derivatives antiarol (5), gentisic acid (6), coniferyl alcohol (7), epoxyconiferyl alcohol (8) and ferulic acid (9), the apocarotenoid vomifoliol (10) , and the flavonoid naringenin (11) . On the other hand, from the methanol extract two types of metabolites were identified: the flavonoids naringenin (11), 7,4 -dimethoxytaxifolin (7,4 -dimethoxydihydroquercetin, 12), aromadendrin (13), kaempferol (14) , taxifolin (dihydroquercetin, 15), prunin (naringenin-7-O-β-D-glucoside, 16), populnin (kaempferol-7-O-β-D-glucoside, 17) and senecin (aromadendrin-7-O-β-D-glucoside, 18); along with the lignans kobusin (19) and pinoresinol (20) (Figure 1 ). Vomifoliol (10) and naringenin (11) were the major constituents of the dichloromethane extract, while the flavonoids naringenin (11) and senecin (18) were isolated as the major components from the methanol extract. The structures for compounds 1-20 were established by the analysis of their 1 H and 13 C NMR (1D and 2D experiments) and MS spectra parameters and its comparison with those reported in the literature. The unequivocal 1 H-and 13 C-NMR assignments for compound 2 are reported here for the first time. Six of these 20 compounds (3, 4, 11, 13, 15 and 20) had been previously isolated from Cochlospermum vitifolium, however all other compounds were isolated here for the first time from this plant and from this genus. Compounds 1-20 belong to either the sterols; C6, C6-C1 and C6-C3 aromatic compounds; apocarotenoids; flavonoids and lignans groups, which are the most frequently identified compounds in this genus.
Previous studies have been conducted to demonstrate the antihypertensive [19] [20] [21] 23 ], hypoglycemic and antidiabetic [22] , immunomodulatory [23] and anti-inflammatory [24] effects of Cochlospermum vitifolium extracts. An exhaustive revision of the existing literature indicated that several of the compounds isolated in this research (Figure 1 ) can be associated to its popular use as different liver treatments. Due to the fact that this plant is broadly used as a treatment for jaundice, hepatitis C and other liver ailments in Mexican traditional medicine, its methanol extract was administrated at a dose of 100 mg/kg to bile duct-obstructed rats, to determine its hepatoprotective activity, showing a statistically significant decrease of serum glutamic-pyruvic transaminase (PGT, 45%) and alkaline phosphatase (APh, 15%) [19] .
The importance of such activities lie in the fact that hepatic diseases (which comprise several conditions, such as: cirrhosis, hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, cholestatic and drug-induced liver diseases and liver cancer) are extremely high-priced in terms of human suffering, loss of productivity, and medical or hospital consultations. In fact, chronic liver diseases are the major cause of mortality worldwide. In 2013, 29 million people in Europe suffered from a chronic liver condition [25] and more than 30 million Americans had hepatic disease [26] . In China, liver diseases, viral hepatitis (predominantly hepatitis B virus), non-alcoholic fatty liver and alcoholic liver disease affect approximately 300 million people [27] . From a physiopathological perspective, most chronic liver diseases begin as an inflammatory process which evolves into focal fibrosis, and afterwards, to complete fibrosis of the gland (hepatic cirrhosis), which increases the risk Six of these 20 compounds (3, 4, 11, 13, 15 and 20) had been previously isolated from Cochlospermum vitifolium, however all other compounds were isolated here for the first time from this plant and from this genus. Compounds 1-20 belong to either the sterols; C 6 , C 6 -C 1 and C 6 -C 3 aromatic compounds; apocarotenoids; flavonoids and lignans groups, which are the most frequently identified compounds in this genus.
The importance of such activities lie in the fact that hepatic diseases (which comprise several conditions, such as: cirrhosis, hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, cholestatic and drug-induced liver diseases and liver cancer) are extremely high-priced in terms of human suffering, loss of productivity, and medical or hospital consultations. In fact, chronic liver diseases are the major cause of mortality worldwide. In 2013, 29 million people in Europe suffered from a chronic liver condition [25] and more than 30 million Americans had hepatic disease [26] .
In China, liver diseases, viral hepatitis (predominantly hepatitis B virus), non-alcoholic fatty liver and alcoholic liver disease affect approximately 300 million people [27] . From a physiopathological perspective, most chronic liver diseases begin as an inflammatory process which evolves into focal fibrosis, and afterwards, to complete fibrosis of the gland (hepatic cirrhosis), which increases the risk of liver cancer. This leads to severe hepatic injury and ultimately to liver failure and other complications.
Thirteen of the twenty compounds isolated from Cochlospermum vitifolium have previously exhibited in vitro and in vivo beneficial liver effects. β-Sitosterol (3) decreased hepatofibrosis [28] , protecting against CCl 4 -induced hepatotoxicity [29] in animal models. Stigmasterol (4) induced apoptosis in hepatocarcimona (HepG2) cells being a potential antineoplastic therapeutic agent [30] . Gentisic acid (6) showed anti-inflammatory and antimutagenic properties, demonstrating protective effects against induced genotoxicity and hepatotoxicity [31] . On the other hand, coniferyl alcohol (7) had a moderated anti-hepatitis B virus (HBV) activity [32] . Ferulic acid (9) had an in vivo hepato-protective effect against the CCl 4 -and formaldehyde-induced hepatotoxicity [33] and also a capacity to inhibit the development of hepatic fibrosis by activation of Hepatic Stellate Cells (HSCs) in the presence of liver damage [34] . Vomifoliol (10) showed moderate activity against human hepatocarcinoma Hep3B cells [35] . Naringenin (11) had a potent lipid-lowering effect reducing the hepatic lipogenesis in rats and acting as an insulin sensitizer in vivo [36] , thus, preventing rat liver damage caused by lead acetate, arsenic and high glucose. Furthermore, this same compound suppresses the metastatic potential of hepatocellular carcinoma [37] . Additionally, aromadendrin (13) possessed radical scavenging and activity against inflammatory, tumor and diabetic processes [38] . Kaempferol (14) had hepatoprotective effects in CCl 4 -, drug-and alcoholic-induced liver injury, constituting a promising therapeutic option for patients with atherosclerotic disease [39] . Taxifolin (15) had antioxidant and cytoprotective effects that prevent and help treat fulminant hepatitis and hepatitis caused CCl 4 [40] . This natural flavonoid is licensed as Silymarin (Legalon ® ), a drug used for the treatment of toxic liver damage, chronic inflammatory liver disease and liver cirrhosis. Prunin (16) showed activity against the hepatitis B (HBV) virus with an IC 50 of 41.59 µM [41] . Administered at a dose of 25 mg/kg, populnin (17) exhibited in vivo hepatoprotective effects against CCl 4 -and D-GalN-induced hepatotoxicity, preventing the development of hepatic lesions [42] . Finally, at 50 and 100 mg/kg, the lignane pinoresinol (20) showed hepatoprotective effects improving CCl 4 -induced liver injury [43] . All these liver beneficial effects from the compounds isolated from Cochlospermum vitifolium directly correlate with its traditional use in Mexican medicine.
Materials and Methods

General Procedures
Compounds 1-20 were purified by successive open column chromatography (CC) using silica gel (70-230 and 230-400 mesh, Sigma-Aldrich, Toluca, México). The isolation procedures and purity of compounds were monitored by thin layer chromatography (TLC) using precoated silica gel 60 F 254 aluminium sheets, visualizing with UV-light and subsequently spraying the plates with (NH 4 ) 4 Ce(SO 4 ) 4 in 2 N H 2 SO 4 (Sigma-Aldrich, Toluca, México). All 1 H-, 13 C-and 2-D NMR experiments were performed in CDCl 3 on a Varian Unity 400 spectrometer (Varian, Inc., Palo Alto, CA, USA) equipped with a 5 mm inverse detection pulse field gradient probe at 25 • C, at 400 MHz for 1 H-NMR and 100 MHz for 13 C-NMR. Chemical shifts were referenced to tetramethylsilane as an internal standard.
Plant Material
The wood of Cochlospermum vitifolium was collected from "Sierra de Huautla" (20 • 
Extraction and Isolation
Throughout three months the wood of this plant was dried at room temperature. The dried and ground wood (1.65 kg) was extracted with CH 2 Cl 2 and MeOH. These extracts were dried under a vacuum to render 11.9 g (0.72% yield) and 25.8 g (1.56% yield) of residue, respectively. 3) collecting 56 fractions of 20 mL to yield naringenin (11, 41 mg, 0.0024%) and 7,4 -dimethoxy-taxifolin (12, 21 mg, 0.0013%). Fractions 77-83 (52 mg) were subjected to a preparative TLC (2 mm × 20 cm, eluent n-hexane:AcOEt 7:3 twice) to yield 30 mg (0.0018%) of a 6:4 mixture of 13 and kaempferol (14) . Fractions 100-111 (49 mg) were subjected to a preparative TLC (2 mm × 20 cm, eluent n-hexane:AcOEt 7:3 twice) to yield kobusin (19, 19 1H, m, H-16b), 1.53 (1H, m, H-16a), 1.51 (1H, m, H-25), 1.32 (1H, m, H-12b), 1.30 (1H, m,  H-17), 1.06 (3H, d, J = 6.4, H-21), 1.00 (3H, s, H-19), 0.96 (3H, s, H-18 
Conclusions
Cochlospermum vitifolium biosynthesizes among other compounds the sterols 3 and 4, the aromatic compounds 6, 7 and 9, the apocatrotenoid 10, the flavonoids 11 and 13-17, and the lignan 20, which have demonstrated beneficial activity to alleviate different liver diseases. The presence of these compounds in the plant agrees with its traditional use in Mexican medicine and some are even included in commercial pharmaceutical formulations used in the treatment of hepatopathies. Their presence within Cochlospermum vitifolium extracts indicates that this plant could be an active hepatoprotective agent. However, the human consumption of this plant must be subjected to toxicity, pharmacodynamic and pharmacokinetic studies to determine how it can be a health contributor.
The isolated metabolites in this study and the chemical composition previously reported for Cochlospermum vitifolium agree with the metabolic content within other Cochlospermum species. The flavonoids, sterols, carotenoids, apocarotenoids and lignans isolated here have chemotaxonomic significance within this genus. This is the first report of compounds 1-2, 5-10, 12, 14, 16-19 from Cochlospermum vitifolium. 
